Chromosome segregation errors: a double-edged sword - TI Pharma
Chromosome segregation errors: a double-edged sword - TI Pharma
Chromosome segregation errors: a double-edged sword - TI Pharma
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
A<br />
B<br />
C<br />
percentage of cells<br />
% PI positive cells<br />
control cenp-e<br />
siRNA<br />
0 5 0 5 0 5 0 5 nM taxol<br />
20<br />
15<br />
10<br />
5<br />
0<br />
n=71<br />
- doxycycline<br />
0 5 0 5 0 5 0 5<br />
+ doxycycline<br />
(Mad2 depleted)<br />
nM taxol<br />
control cenp-e control cenp-e siRNA<br />
- doxycycline + doxycycline<br />
(Mad2 depleted)<br />
time-lapse (H2B-GFP)<br />
n=63<br />
n=38<br />
n=29<br />
n=69<br />
n=65<br />
n=36<br />
n=34<br />
control cenp-e<br />
D<br />
E<br />
relative signal<br />
intensity CENP-E/<br />
CREST<br />
F time-lapse (DIC) G<br />
U2OS-TetR-Mad2<br />
VH10-TetR Mps1<br />
600<br />
500<br />
100<br />
100<br />
400<br />
80<br />
80<br />
300<br />
60<br />
60<br />
200<br />
40<br />
40<br />
100<br />
20<br />
0<br />
0 5 0 5 0 5 0 5 nM taxol<br />
20<br />
0<br />
0 2 0 2 nM taxol<br />
0<br />
control cenp-e control cenp-e siRNA - + doxycycline<br />
- doxycycline<br />
no <strong>segregation</strong> defects<br />
+ doxycycline<br />
(Mad2 depleted)<br />
mild <strong>segregation</strong> defects (1-5)<br />
severe <strong>segregation</strong> defects (>5)<br />
percentage of cells<br />
n=27<br />
n=56<br />
n=39<br />
n=28<br />
x1000 cells<br />
1,2<br />
0,8<br />
0,4<br />
0<br />
Mad2<br />
actin<br />
- + doxycycline<br />
control<br />
cenp-e<br />
control<br />
cenp-e<br />
control<br />
cenp-e<br />
control<br />
cenp-e<br />
siRNA<br />
siRNA<br />
CREST CENP-E merge w/DNA<br />
- + doxycycline<br />
VH10-TetR Mps1<br />
day 0<br />
day 2<br />
day 4<br />
day 7 day 9<br />
- dox<br />
+ dox<br />
- dox + 2nM tax<br />
+ dox + 2nM tax<br />
control siRNA<br />
cenp-e siRNA<br />
Figure S10.<br />
A) Representative pictures of colony formations of U2OS-TetRMad2 cells on day 6 treated with or without doxycycline (day 0),<br />
control or CENP-E siRNA (day 2) and 0 or 5nM taxol (day 3). Luciferase or GAPDH siRNA were used as a control. B) Automated analysis<br />
of the percentage of PI positive over Hoechst positive U2OS-TetRMad2 cells on day 6 after treatment as in (A). Bars represent the<br />
average of 4 independent experiments (+SEM). C) Quantification of time-lapse analysis as in Fig.S1C. siRNA transfections were<br />
performed 36 hours prior to filming. Indicated taxol concentrations were added 1 hour prior to filming. n represents amount of cells<br />
filmed. D) Immunoblots of Mad2 and actin of U2OS-TetRMad2 cells treated with and without doxycycline and control or CENP-E<br />
siRNA. E) Top: Localization of CENP-E (green) and CREST (red) in mitotic U2OS-TetRMad2 cells transfected with control or CENP-E<br />
siRNA. Bottom: Quantification of intensity of CENP-E staining over CREST. Average is shown of 35 kinetochores +SD of 7 analyzed<br />
cells per condition. F) Quantification of time-lapse analysis (DIC) of chromosome <strong>segregation</strong> in anaphase in VH10 cells. n indicates<br />
amount of cells filmed. G) Growth curve of VH10-TetRMps1 cells after indicated treatments. On day 0 doxycycline was added, on<br />
day 2 2nM of taxol was added where indicated.<br />
105<br />
<strong>Chromosome</strong> mis<strong>segregation</strong>s kill tumor cells<br />
5